Home
Ishita Drugs & Industries Ltd Board of Directors
Board of Directors at Ishita Drugs & Industries Ltd
Abha Agrawal
Non Executive Director
Arvind Sapkal
Director
Govind Gupta
Director
Jagdish Agrawal
Managing Director
Niranjan Agrawal
Director
Key Highlights
- Jagdish Agrawal continues to serve as the Managing Director in 2024, maintaining the same position as in the previous year.
- Abha Agrawal continues to serve as the Non Executive Director in 2024, maintaining the same position as in the previous year.
- Arvind Sapkal continues to serve as the Director in 2024, maintaining the same position as in the previous year.
- Srushti Pandya continues to serve as the Company Sec. & Compli. Officer in 2024, maintaining the same position as in the previous year.
- Dhwani Jaypalsinh Solanki joins the board as Independent Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Ishita Drugs & Industries Ltd
NSE: ISHITADRUGS
Share Price
Last Ten Days Market Price
| Date |  Price (₹) |
|---|---|
| 15 Jan 2025 | 86.22 |
| 14 Jan 2025 | 86.79 |
| 13 Jan 2025 | 82.25 |
| 10 Jan 2025 | 87.53 |
| 09 Jan 2025 | 92.06 |
| 08 Jan 2025 | 92.71 |
| 07 Jan 2025 | 95.65 |
| 06 Jan 2025 | 94.1 |
| 03 Jan 2025 | 96.35 |
| 02 Jan 2025 | 94 |
Company Fundamentals for Ishita Drugs & Industries Ltd
Market Cap
25 Cr
EPS
2.5
P/E Ratio (TTM)
34.6
P/B Ratio (TTM)
2.5
Day’s High
86.65
Day’s Low
86.22
DTE
0.2
ROE
7.2
52 Week High
104.75
52 Week Low
56.0
ROCE
8.5
Market Price of Ishita Drugs & Industries Ltd
1M
1Y
3Y
5Y
Monitoring Ishita Drugs & Industries Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
Ishita Drugs & Industries Ltd News Hub
Ishita Drugs & Industries standalone net profit rises 7.14% in the June 2024 quarter
Net profit of Ishita Drugs & Industries rose 7.14% to Rs 0.15 crore in the quarter ended June 2024 a
Read more
14 Aug 2024
Ishita Drugs & Industries to declare Quarterly Result
Ishita Drugs & Industries will hold a meeting of the Board of Directors of the Company on 13 August
Read more
10 Aug 2024
Ishita Drugs & Industries AGM scheduled
Ishita Drugs & Industries announced that the Annual General Meeting (AGM) of the company will be hel
Read more
28 Aug 2024
Ishita Drugs & Industries standalone net profit declines 9.52% in the September 2024 quarter
Net profit of Ishita Drugs & Industries declined 9.52% to Rs 0.19 crore in the quarter ended Septemb
Read more
13 Nov 2024
Document
Annual Reports
N/A
Credit Ratings
N/A
Concalls
Data not available
Data not available
FAQs for Board of Directors of Ishita Drugs & Industries Ltd
How are members of Ishita Drugs & Industries Ltd Board of Directors selected?
Members of the Ishita Drugs & Industries Ltd Board of Directors are typically selected based on their expertise, experience, and alignment with Ishita Drugs & Industries Ltd’s strategic goals. Appointments are made by the nomination and remuneration committee and approved by shareholders. However, the selection process does vary from company to company.
Can shareholders interact with the Ishita Drugs & Industries Ltd Board of Directors?
Shareholders can interact with the Ishita Drugs & Industries Ltd Board of Directors during the Annual General Meeting (AGM) and through formal communications or queries submitted to the company wherein they have the opportunity to ask questions and provide feedback on the business. Please note different companies have different protocols for shareholders who want to meet the Board of Directors.
How often does the Ishita Drugs & Industries Ltd Board of Directors meet?
The Ishita Drugs & Industries Ltd Board of Directors typically meets quarterly. However, special meetings may be summoned as needed to address urgent matters. The frequency can vary depending on business needs and regulatory requirements to ensure ongoing oversight and strategic guidance for the company. A scheduled meeting among the Board of Directors may vary from company to company.
What are the responsibilities of the Ishita Drugs & Industries Ltd Board of Directors?
The Ishita Drugs & Industries Ltd Board of Directors is responsible for setting strategic goals, overseeing company performance, ensuring effective governance, and safeguarding shareholder interests. They provide high-level guidance on corporate policies and risk management. Additionally, they appoint and evaluate senior management and ensure compliance with legal and regulatory requirements. Please note the roles and responsibilities of the Board of Directors may be different from company to company.
Who are the current members of the Board of Directors at Ishita Drugs & Industries Ltd?
The current Board of Directors at Ishita Drugs & Industries Ltd includes Jagdish Agrawal( Managing Director) ,Abha Agrawal( Non Executive Director) ,Arvind Sapkal( Director) ,Srushti Pandya( Company Sec. & Compli. Officer) ,Dhwani Jaypalsinh Solanki( Independent Director) . The full list can be found on Ishita Drugs & Industries Ltd’s official website or recent corporate filings.
Popular Search
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
